PitchBook：2025年二季度制药生物工具风险投资趋势报告（英文版）

The pharma biotools industry encompasses instruments, technologies, and services supporting drug discovery, biopharmaceutical manufacturing, and diagnostics. The space has progressed beyond basic laboratory equipment, evolving into a field defined by sophisticated platforms that integrate digital technologies into traditional wet lab approaches and provide tech-enabled services tailored to emerging therapeutic modalities. With drug developers weathering a downturned funding environment,1 inno